Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urology

G W Chodak1

  • 1University of Chicago Pritzker School of Medicine, Ill.

JAMA
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Prostate cancer screening involves prostate-specific antigen (PSA) levels influenced by age and prostate size. For men over 70 with localized cancer, surgery or radiation offers minimal benefit compared to watchful waiting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?

The Journal of urology·2006
Same author

Watchful waiting for prostate cancer: a review article.

Prostate cancer and prostatic diseases·2006
Same author

Re: Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

The Journal of urology·2005
Same author

Can leakage at the vesico-urethral anastomosis be predicted after radical retropubic prostatectomy?

BJU international·2004
Same author

Current trends in the management of radical retropubic prostatectomy: is short-stay RRP feasible in the United Kingdom?

Prostate cancer and prostatic diseases·2004
Same author

Prostatectomy - a radical approach.

BJU international·2003

Area of Science:

  • Urology
  • Oncology
  • Geriatrics

Background:

  • Prostate-specific antigen (PSA) levels are critical biomarkers in prostate cancer detection and management.
  • Age and prostate volume are known confounders of PSA levels, necessitating age-adjusted reference ranges.
  • Treatment decisions for localized prostate cancer require careful consideration of patient age and potential benefits.

Purpose of the Study:

  • To investigate the influence of age and prostate volume on prostate-specific antigen (PSA) levels.
  • To evaluate the comparative effectiveness of radical prostatectomy, radiation therapy, and watchful waiting for localized prostate cancer in men over 70.

Main Methods:

  • Analysis of factors affecting PSA levels, including patient age and prostate volume.
  • Comparative analysis of treatment outcomes for localized prostate cancer in elderly men.

Related Experiment Videos

Main Results:

  • Both advanced age and increased prostate volume significantly impact PSA levels, suggesting the need for variable normal ranges.
  • The incremental benefit of aggressive treatments (radical prostatectomy or radiation therapy) over conservative management (watchful waiting) is negligible for men aged 70 and above with localized prostate cancer.

Conclusions:

  • PSA interpretation must account for patient age and prostate size to avoid misdiagnosis.
  • Watchful waiting is a viable and potentially preferable management strategy for localized prostate cancer in men over 70 due to minimal gains from radical treatments.